ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Coronavirus Infections
Communicable Diseases
Human Influenza
Post-Acute COVID-19 Syndrome
Pneumonia
Syndrome

COVID-19 trials near Salt Lake City, UT, USA:

Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States (SHIELD)

To assess the impact of reactogenicity among health care workers and first responders receiving an updated 2024-25 Novavax COVID-19-...

Active, not recruiting
COVID-19
SARS CoV 2 Infection
Biological: Pfizer mRNA COVID-19 vaccine
Biological: protein subunit: Novavax COVID-19 vaccine

Phase 4

Novavax
Novavax

Salt Lake City, Utah, United States

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID...

Enrolling
COVID-19
Biological: CVXGA (CVXGA50)
Biological: COMIRNATY®

Phase 2

Cyanvac

West Jordan, Utah, United States and 14 other locations

The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection (BEEHIVE)

The purpose of this research study is to find out how well two different 2023-2024 updated COVID-19 vaccines protect people from CO-...

Enrolling
COVID-19
SARS CoV 2 Infection
Biological: Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
Biological: Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)

Phase 4

Sarang K. Yoon, DO, MOH

Salt Lake City, Utah, United States

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

of the study is to assess the safety and immunogenicity of IIV-HD (high-dose inactivated influenza vaccine) + rC19 (adjuvanted recombinant COVID...

Enrolling
COVID-19 Immunization
Influenza Immunization
Biological: IIV-HD + rC19 (dose 4)
Biological: IIV-HD + rC19 (dose 3)

Phase 1, Phase 2

Sanofi
Sanofi

Salt Lake City, Utah, United States and 11 other locations

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 (NextCOVE)

The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...

Active, not recruiting
COVID-19
Biological: mRNA-1283.222
Biological: mRNA-1273.815

Phase 3

Moderna
Moderna

Salt Lake City, Utah, United States and 217 other locations

A Study to Evaluate VXA-CoV2-3.1 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

(SARS-CoV2) vaccine tablet VXA-CoV2-3.1 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID...

Enrolling
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: COMIRNATY®

Phase 2

Vaxart

Salt Lake City, Utah, United States and 144 other locations

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Sub-study)
Biological: Placebo (Parent study Sentinel Safety Cohort)

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Salt Lake City, Utah, United States and 214 other locations

A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

be tolerated for treatment of pregnant women with mild or moderate COVID-19 compared to non-pregnant women with mild or moderate CO-...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 1

Pfizer
Pfizer

Salt Lake City, Utah, United States and 32 other locations

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 2, Phase 3

Pfizer
Pfizer

Salt Lake City, Utah, United States and 109 other locations

A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.

the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...

Enrolling
Myocarditis
Diagnostic Test: Cardiac Imaging

Phase 4

Pfizer
Pfizer

Salt Lake City, Utah, United States and 39 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2025 Veeva Systems